newsfilter
← Latest News
PR Newswire·

CTI BioPharma Presents Pivotal Data from Pacritinib Program at the 2022 American Society of Clinical Oncology Annual Meeting

SEATTLE, May 26, 2022 /PRNewswire/ -- CTI BioPharma Corp. (NASDAQ:CTIC) today announced a poster presentation from the Company's pacritinib program at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, being held in Chicago and virtual